You are here
- Home
- Therapy Areas
- Neuroscience
A Phase IIb, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Efficacy and Safety Study of Adjuntive AZD6765 in Subjects with Severe Major Depressive Disorder (MDD) and a History of Poor Response to Antidepressants
- Disease
- depressive disorder
- Drug Name
- AZD6765
- Generic Name
- AZD6765
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- II
- Start Date
- Oct 31, 2008
- Study Name
- D6702C00009
- Study Id
- D6702C00009
- ClinicalTrials.gov ID
- NCT00781742
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
